{"id":438715,"date":"2025-08-30T17:46:02","date_gmt":"2025-08-30T15:46:02","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=438715"},"modified":"2025-08-30T17:46:02","modified_gmt":"2025-08-30T15:46:02","slug":"naucnici-macke-mozda-drze-kljuc-za-lijecenje-raka-kod-ljudi","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2025\/08\/30\/naucnici-macke-mozda-drze-kljuc-za-lijecenje-raka-kod-ljudi\/","title":{"rendered":"Nau\u010dnici: Ma\u010dke mo\u017eda dr\u017ee klju\u010d za lije\u010denje raka kod ljudi"},"content":{"rendered":"<p>Nova vrsta ciljane terapije za lije\u010denje raka glave i vrata (HNSCC) kod ma\u010daka mogla bi biti klju\u010dna za razvoj sli\u010dnih terapija kod ljudi, prema novoj studiji, <a href=\"https:\/\/www.independent.co.uk\/news\/science\/cats-pets-humans-cancer-head-neck-clinical-trial-b2816317.html\" target=\"_blank\" rel=\"noopener\">prenosi<\/a> Indipendent.<\/p>\n<p>Studija koja je uklju\u010divala 20 ma\u010daka s ovim rakom sugeri\u0161e da bi ku\u0107ni ljubimci mogli biti bolji modeli od mi\u0161eva za testiranje ljekova za ovo stanje kod ljudi. Istra\u017eiva\u010di su u studiji otkrili da je kod vi\u0161e od tre\u0107ine ma\u010daka koje su primile terapiju bila pod kontrolom uz minimalne nuspojave, \u0161to ukazuje da bi lijek mogao biti efikasan i za ljude.<\/p>\n<p>Rije\u010d je o prvom lijeku koji cilja molekul STAT3, koji kontroli\u0161e ekspresiju nekih gena i prisutan je u nizu \u010dvrstih i te\u010dnih tumora, uklju\u010duju\u0107i slu\u010dajeve HNSCC-a. Rakovi poput HNSCC poznati su po tome \u0161to su izuzetno te\u0161ki za lije\u010denje kod ma\u010daka ku\u0107nih ljubimaca, a ve\u0107ina \u017eivotinja s ovim stanjem umre unutar 2 do 3 mjeseca od uspostavljanja dijagnoze.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nova vrsta ciljane terapije za lije\u010denje raka glave i vrata (HNSCC) kod ma\u010daka mogla bi biti klju\u010dna za razvoj sli\u010dnih terapija kod ljudi<\/p>\n","protected":false},"author":1,"featured_media":432918,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-438715","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/438715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=438715"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/438715\/revisions"}],"predecessor-version":[{"id":438718,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/438715\/revisions\/438718"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/432918"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=438715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=438715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=438715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}